S&P 500

Bristol Myers Squibb (BMY) — 10-Year DCF Projection Model

Free stock research tool. Build a 10-year revenue, earnings (EPS), and free cash flow forecast for Bristol Myers Squibb (BMY) stock, a company in the Health Care (Pharmaceuticals) sector. Pulls audited SEC EDGAR XBRL financials, triangulates Wall Street analyst consensus across Yahoo Finance, NASDAQ, and StockAnalysis, and overlays AI-clustered news + social event probabilities directly onto projected EPS. For equity research — not personal budgeting or accounting.

Build BMY projection model →Browse all stocks

Bristol Myers Squibb at a glance

Ticker
BMY
Company
Bristol Myers Squibb
Sector
Health Care
Sub-industry
Pharmaceuticals
Headquarters
New York City, New York
Founded
1989 (1887)
Added to S&P 500
1957-03-04
Index membership
S&P 500

What you'll see in your BMY model

  • 10 years of audited historical financials for Bristol Myers Squibb, sourced directly from the SEC's EDGAR XBRL filings (10-K and 10-Q).
  • Triangulated Wall Street consensus for BMY's forward revenue, EBITDA, and EPS across Yahoo Finance, NASDAQ, and StockAnalysis with cross-source dispersion (σ).
  • AI Event Factors: top-10 news/social themes for BMY with probability sliders and live EPS impact.
  • Sensitivity tables and Excel export for every assumption.

About Bristol Myers Squibb

Bristol Myers Squibb (NYSE/NASDAQ: BMY) was founded in 1989 (1887) and is headquartered in New York City, New York. The company operates in the Health Care sector (Pharmaceuticals sub-industry) and is a constituent of the S&P 500. Our projection model builds a clean discounted-cash-flow view of Bristol Myers Squibb in roughly five seconds and lets you adjust every assumption to test your own thesis.